Therapore, produced by Avant Immunotherapeutics, is a technology that uses a protein delivery system to carry viral
proteins into human cells to generate a specific immune response, not only to the Hep C virus, but other viruses, as well.
This technology can be used to create vaccines. Avant hopes that this system will be particularly effective in treating chronic
infections such as hepatitis C. The company claims that Therapore technology is highly efficient, causing potent immune responses
with the use of minute quantities. Therapore is also able to deliver large peptides and proteins to the cell for processing,
possibly creating a broad range of immunity. It is in preclinical trials for HIV (
).
